相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Suppression of Liver Tumor Growth and Metastasis by Adiponectin in Nude Mice through Inhibition of Tumor Angiogenesis and Downregulation of Rho Kinase/IFN-Inducible Protein 10/Matrix Metalloproteinase 9 Signaling
Kwan Man et al.
CLINICAL CANCER RESEARCH (2010)
Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and In Vitro
Jun Yu et al.
HEPATOLOGY (2010)
Epithelial-to-Mesenchymal Transition of Murine Liver Tumor Cells Promotes Invasion
Wei Ding et al.
HEPATOLOGY (2010)
Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer
Kyung Hee Lee et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition
Ajaya Kumar Reka et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Peroxisome Proliferator-Activated Receptor-y Inhibits Transformed Growth of Non-Small Cell Lung Cancer Cells through Selective Suppression of Snail
Rashmi Choudhary et al.
NEOPLASIA (2010)
Cell Adhesion Molecules: Role and Clinical Significance in Cancer
Nektaria Makrilia et al.
CANCER INVESTIGATION (2009)
Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest
Olivier Bailet et al.
CANCER RESEARCH (2009)
Does the Expression of Cyclin E, pRb, and p21 Correlate with Prognosis in Gastric Adenocarcinoma?
Gregory Kouraklis et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Methylation of Protocadherin 10, a Novel Tumor Suppressor, Is Associated With Poor Prognosis in Patients With Gastric Cancer
Jun Yu et al.
GASTROENTEROLOGY (2009)
Role of the Protein Tyrosine Kinase Syk in Regulating Cell-Cell Adhesion and Motility in Breast Cancer Cells
Xiaoying Zhang et al.
MOLECULAR CANCER RESEARCH (2009)
Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion
R. M. Larive et al.
ONCOGENE (2009)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells
Karen D. Cowden Dahl et al.
CANCER RESEARCH (2008)
Expression and prognostic role of MMP2, MMP9, MMP13, and MMP14 matrix metalloproteinases in sinonasal and oral malignant melanomas
Svetlana Kondratiev et al.
HUMAN PATHOLOGY (2008)
CHM-1 inhibits hepatocyte growth factor-induced invasion of SK-Hep-1 human hepatocellular carcinoma cells by suppressing matrix metalloproteinase-9 expression
Shih-Wei Wang et al.
CANCER LETTERS (2007)
Prognostic molecular markers in hepatocellular carcinoma: A systematic review
Christopher D. Mann et al.
EUROPEAN JOURNAL OF CANCER (2007)
Effects of PPARγ agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line
Ying Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Association between high collagenase-3 expression levels and poor prognosis in patients with head and neck cancer
M Luukkaa et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
J Yu et al.
HEPATOLOGY (2006)
Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies
RD Sanderson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration
FF Mohammed et al.
HEPATOLOGY (2005)
Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hernatogenous metastasis, and prognosis
T Sato et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Antineoplastic effects of peroxisome proliferator-activated receptor γ agonists
C Grommes et al.
LANCET ONCOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Role of matrix metalloproteinases and their inhibitors in tumor invasion and metastasis
PZ Khasigov et al.
BIOCHEMISTRY-MOSCOW (2003)
Frequent methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene in pancreatic endocrine tumors
A Wild et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1
I Ozaki et al.
HEPATOLOGY RESEARCH (2003)
PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis
D Panigrahy et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition
G Maulik et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2002)
Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells
A Monvoisin et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Ligands for peroxisome proliferator-activated receptor γ inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells
K Ohta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells
PJP Coopman et al.
NATURE (2000)
分享论文
